Quick Answer
KEWAUNEE SCIENTIFIC CORP /DE/ reported Total Revenue of $240.47 million for fiscal year 2025.
KEWAUNEE SCIENTIFIC CORP /DE/ — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $240.47M +18.0% |
$203.75M -7.2% |
$219.49M +30.0% |
$168.87M +14.5% |
$147.47M -0.0% |
$147.54M +0.7% |
| Revenue (ASC 606) | $240.47M +18.0% |
$203.75M -7.2% |
$219.49M +30.0% |
$168.87M +14.5% |
$147.47M -0.0% |
$147.54M +0.7% |
| Net Income | $11.40M -39.2% |
$18.75M +2441.1% |
$738.0K +112.0% |
-$6.13M -66.8% |
-$3.67M +21.7% |
-$4.69M -406.5% |
| Diluted EPS | $3.83 -40.0% |
$6.38 +2452.0% |
$0.25 +111.4% |
-$2.20 -65.4% |
-$1.33 +21.8% |
-$1.70 -409.1% |
| Total Assets | $194.65M +44.4% |
$134.77M +13.3% |
$118.90M +0.1% |
$118.77M +32.9% |
$89.38M +6.5% |
$83.93M -3.8% |
| Cash and Equivalents | $14.94M -35.8% |
$23.27M +188.0% |
$8.08M +82.2% |
$4.43M -14.8% |
$5.21M +19.3% |
$4.37M -59.0% |
| Long-Term Debt | — | — | — | — | — | $0.00 -100.0% |
| Stockholders Equity | $64.46M +17.7% |
$54.76M +46.4% |
$37.41M +4.8% |
$35.69M -13.5% |
$41.24M +7.4% |
$38.41M -18.4% |
| Operating Income | $17.76M -2.9% |
$18.28M +240.8% |
$5.36M +305.7% |
-$2.61M -98.2% |
-$1.32M +43.9% |
-$2.35M -211.0% |
| Gross Profit | $68.86M +32.3% |
$52.05M +46.3% |
$35.59M +46.9% |
$24.22M +0.9% |
$23.99M +2.4% |
$23.43M -7.5% |
| Shares Outstanding | 2.84M +0.0% |
2.84M +0.3% |
2.83M +1.4% |
2.79M +1.0% |
2.76M +0.4% |
2.75M +0.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | January 31, 2026 | $69.40M | +3.3% | -1.0% |
| Revenue (ASC 606) | January 31, 2026 | $69.40M | +3.3% | -1.0% |
| Net Income | January 31, 2026 | $692.0K | -48.9% | -71.7% |
| Diluted EPS | January 31, 2026 | $0.23 | -48.9% | -72.0% |
| Total Assets | January 31, 2026 | $175.96M | -7.0% | -6.9% |
| Cash and Equivalents | January 31, 2026 | $8.15M | -13.8% | -35.3% |
| Long-Term Debt | January 31, 2020 | $0.00 | -100.0% | — |
| Stockholders Equity | January 31, 2026 | $70.67M | +16.2% | +1.2% |
| Operating Income | January 31, 2026 | $2.58M | +14.8% | -37.1% |
| Gross Profit | January 31, 2026 | $18.55M | +0.9% | -6.0% |
| Shares Outstanding | January 31, 2026 | 2.87M | -0.2% | +0.0% |
- KEWAUNEE SCIENTIFIC CORP /DE/ reported Total Revenue of $240.47 million for fiscal year 2025.
- KEWAUNEE SCIENTIFIC CORP /DE/ showed an increase of +18.0% in Total Revenue compared to the prior fiscal year.
- KEWAUNEE SCIENTIFIC CORP /DE/ reported Revenue (ASC 606) of $240.47 million for fiscal year 2025.
- KEWAUNEE SCIENTIFIC CORP /DE/ showed an increase of +18.0% in Revenue (ASC 606) compared to the prior fiscal year.
- KEWAUNEE SCIENTIFIC CORP /DE/ reported Net Income of $11.40 million for fiscal year 2025.
- KEWAUNEE SCIENTIFIC CORP /DE/ showed a decrease of -39.2% in Net Income compared to the prior fiscal year.
- KEWAUNEE SCIENTIFIC CORP /DE/ reported Diluted EPS of $3.83 per share for fiscal year 2025.
- KEWAUNEE SCIENTIFIC CORP /DE/ showed a decrease of -40.0% in Diluted EPS compared to the prior fiscal year.
- KEWAUNEE SCIENTIFIC CORP /DE/ reported Total Assets of $194.65 million for fiscal year 2025.
- KEWAUNEE SCIENTIFIC CORP /DE/ showed an increase of +44.4% in Total Assets compared to the prior fiscal year.
- KEWAUNEE SCIENTIFIC CORP /DE/ reported Cash and Equivalents of $14.94 million for fiscal year 2025.
- KEWAUNEE SCIENTIFIC CORP /DE/ showed a decrease of -35.8% in Cash and Equivalents compared to the prior fiscal year.
- KEWAUNEE SCIENTIFIC CORP /DE/ reported Long-Term Debt of $0.00 for fiscal year 2020.
- KEWAUNEE SCIENTIFIC CORP /DE/ showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- KEWAUNEE SCIENTIFIC CORP /DE/ reported Stockholders Equity of $64.46 million for fiscal year 2025.
- KEWAUNEE SCIENTIFIC CORP /DE/ showed an increase of +17.7% in Stockholders Equity compared to the prior fiscal year.
- KEWAUNEE SCIENTIFIC CORP /DE/ reported Operating Income of $17.76 million for fiscal year 2025.
- KEWAUNEE SCIENTIFIC CORP /DE/ showed a decrease of -2.9% in Operating Income compared to the prior fiscal year.
- KEWAUNEE SCIENTIFIC CORP /DE/ reported Gross Profit of $68.86 million for fiscal year 2025.
- KEWAUNEE SCIENTIFIC CORP /DE/ showed an increase of +32.3% in Gross Profit compared to the prior fiscal year.
- KEWAUNEE SCIENTIFIC CORP /DE/ reported Shares Outstanding of 2.84 million shares for fiscal year 2025.
- KEWAUNEE SCIENTIFIC CORP /DE/ showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: